Central Automotive Products (8117) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
26 May, 2026Executive summary
Revenue for the six months ended September 2024 was ¥19,439 million, up 1.0% year-over-year.
Operating income rose 3.6% to ¥5,172 million, and net income attributable to shareholders increased 7.9% to ¥4,171 million compared to the same period last year.
Despite a decline in domestic new car sales, the group focused on expanding high-value original products and strengthening new business initiatives.
Financial highlights
Gross profit increased to ¥8,590 million from ¥8,202 million year-over-year.
Ordinary income was ¥5,926 million, up 6.1% year-over-year.
EPS for the period was ¥226.66, up from ¥210.26 in the prior year.
Comprehensive income decreased 22.2% to ¥3,812 million.
Outlook and guidance
Full-year revenue forecast remains unchanged at ¥41,000 million, up 4.2% year-over-year.
Operating income is projected at ¥11,800 million (+6.2%), ordinary income at ¥10,800 million (+4.8%), and net income at ¥8,100 million (+2.2%).
Full-year EPS forecast is ¥439.97.
Dividend forecast revised upward to ¥138 per share for the year.
Latest events from Central Automotive Products
- Q1 FY2025 delivered stable profits and improved equity despite weak new car sales.8117
Q1 202526 May 2026 - Profits rose on higher revenue and segment gains, with guidance maintained for the full year.8117
Q3 202526 May 2026 - Sales and profits rose, with robust cash flow and a positive outlook for FY2026.8117
Q4 202526 May 2026 - Strong quarterly growth in sales and profits, with positive full-year guidance and stock split.8117
Q1 202626 May 2026 - Net sales and profits grew year-over-year, with strong guidance and a recent stock split.8117
Q2 202626 May 2026 - Net sales rose 12.8% and profit attributable to owners of parent increased 11.7% year-over-year.8117
Q3 202626 May 2026 - Sales and profits rose, cash flow strengthened, and FY2027 guidance remains positive.8117
Q4 202626 May 2026